Daniel A. Zweifel

TL;DR: Gold nanorods excited at 830 nm on a far-field laser-scanning microscope produced strong two-photon luminescence (TPL) intensities, with a cos(4) dependence on the incident polarization.

TL;DR: Plasmon-resonant gold nanorods are demonstrated as low backscattering albedo contrast agents for optical coherence tomography (OCT) with high sensitivity in a regime where extinction alone could not discriminate Nanorods.

TL;DR: The growth of gold nanorods can be arrested at intermediate stages by treatment with Na(2)S, providing greater control over their optical resonances, and the blueshift in plasmon resonance that accompanies the dumbbell- to-oblate shape transition correlates more strongly with changes in the length-to-midsection (L/D(1) ratio rather than the length/end width (L-Sayed) ratio.

TL;DR: The potential for using plasmon-resonant gold nanorods as targeted contrast agents for in vivo coherent optical imaging is investigated in this article, where separation of the relative strengths of light scattering and absorption of plasmorons are measured with a double-integrating sphere system at 774 and 1304nm.

TL;DR: Plasmon-resonant gold nanorods have outstanding potential as multifunctional agents for image-guided therapies but their straightforward application for cell-specific labeling is obstructed by the presence of CTAB, a cationic surfactant carried over from nanorod synthesis which also promotes their nonspecific uptake into cells.